CSBR vs KEY · P/E 16, rev $56.9M vs P/E 13, rev $7.51B
Champions Oncology Inc (CSBR) versus KeyCorp (KEY) — a side-by-side from cached financials, not a winner call.
Champions Oncology Inc (CSBR) is a biotechnology company listed on US.
KeyCorp (KEY) is a banks - regional company listed on US.
Latest reported CSBR revenue for 2025-04-30 was $56.9M. Net income was $4.7M. CSBR currently screens at market cap $99.8M and trailing P/E 16.0.
Latest reported KEY revenue for 2025-12-31 was $7.51B. Net income was $1.83B. Revenue was up 62.7% from 2024-12-31 to 2025-12-31. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
CSBR currently screens at market cap $99.8M and trailing P/E 16.0. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
Not investment advice. Open the CSBR and KEY stock pages for the full models.
Not investment advice.